ONESOURCE SPECIALTY PHARMA
|
The Current P/S Ratio of ONESOURCE SPECIALTY PHARMA is 9.90.
| Share Price | ₹1,332.7 | Oct 23,2026 |
| Market Cap | ₹15,286.1 Cr | |
| Sales-TTM | ₹1,543.3 Cr | TTM-Consolidated Results |
| Price/Sales | 9.90x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of ONESOURCE SPECIALTY PHARMA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹15,286.1 Cr] as on Oct 23,2026
(/) Sales [ ₹1,543.3 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 9.90x ]
Thus, for ONESOURCE SPECIALTY PHARMA , the investors are currently willing to pay '9.90 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of ONESOURCE SPECIALTY PHARMA !
The chart below summarizes the trend in P/S Ratio of ONESOURCE SPECIALTY PHARMA over the last five years.
Historical PS (Price/Sales) ratio chart of ONESOURCE SPECIALTY PHARMA
PS Ratio Performance Analysis for ONESOURCE SPECIALTY PHARMA
- ONESOURCE SPECIALTY PHARMA 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 5.14x.
- ONESOURCE SPECIALTY PHARMA 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ONESOURCE SPECIALTY PHARMA 's p/e ratio peaked in Mar2025 at 13.84x.
- ONESOURCE SPECIALTY PHARMA 's p/e ratio hit its five-year low in Mar2024 of 0x.
How does ONESOURCE SPECIALTY PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| ONESOURCE SPECIALTY PHARMA | 1,543.3 | 9.90 | 15,286.1 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 59,910.5 | 6.98 | 418,204.0 |
| DIVIS LABORATORIES LTD | 11,230.0 | 21.24 | 238,497.0 |
| TORRENT PHARMACEUTICALS LTD | 17,400.0 | 9.80 | 170,481.0 |
| CIPLA LTD | 28,324.4 | 3.81 | 108,012.0 |
| DR REDDYS LABORATORIES LTD | 33,097.4 | 3.09 | 102,207.0 |
| MANKIND PHARMA LTD | 14,737.9 | 6.21 | 91,572.1 |
| LUPIN LTD | 29,966.6 | 2.94 | 88,028.3 |
| ZYDUS LIFESCIENCES LTD | 28,591.7 | 3.93 | 112,503.0 |
| AUROBINDO PHARMA LTD | 34,935.3 | 2.58 | 90,294.0 |
| LAURUS LABS LTD | 7,269.6 | 14.67 | 106,658.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs ONESOURCE SPECIALTY PHARMA 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.58x |
| Max industry PS | 21.24x |
| Median industry PS | 6.21x |
| Average industry PS | 7.74x |
You may also like the below Video Courses